Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13884285 | 0.82 | — | — | |
| SCHEMBL98756 | 0.82 | MEN1 (0.33) | — | |
| SCHEMBL173217 | 0.79 | CYP1A2 (0.40) | CYP1A2MAPK1 | |
| SCHEMBL13844236 | 0.78 | ALDH1A1 (0.48) | — | |
| SCHEMBL7931709 | 0.77 | ALDH1A1 (0.31) | — | |
| SCHEMBL24965367 | 0.76 | — | — | |
| SCHEMBL13893518 | 0.76 | — | — | |
| SCHEMBL15471302 | 0.76 | — | — | |
| SCHEMBL7939515 | 0.75 | ALDH1A1 (0.30) | — | |
| SCHEMBL12535907 | 0.75 | CYP1A2 (0.37) | CYP1A2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120058084-A1 | Interferon Alpha Carrier Prodrugs | ASCENDIS PHARMA AS (DK) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120058084-A1 | Interferon Alpha Carrier Prodrugs | IFNG, IFNAR1, IRF3 | CYP1A2 144/4885MAPK1 3981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.